![Anupam Dalal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anupam Dalal
Direktor/Vorstandsmitglied bei
WHITEHAWK THERAPEUTICS, INC.
Vermögen: 5 130 $ am 31.08.2026
Profil
Anupam Akshay Dalal is the founder of Kvp Capital Gp LLC.
Current jobs include Director at Aerpio Therapeutics LLC, Director at Aadi Subsidiary, Inc., Independent Director at Whitehawk Therapeutics, Inc. since 2021, and Chief Investment Officer & Managing Member at Acuta Capital Partners LLC since 2016.
Former jobs include Director at Neurotech Pharmaceuticals, Inc., Independent Director at Akebia Therapeutics, Inc. from 2014 to 2016, Managing Director at Kearny Venture Partners from 2006 to 2016, Director at NewBridge Pharmaceuticals FZ LLC, Director at Taiwan Liposome Co., Ltd., Independent Director at Aerpio Pharmaceuticals, Inc., Principal at Pervasis Therapeutics, Inc., Principal at Resolvyx Pharmaceuticals, Inc., Principal at Flagship Pioneering, LLC, and Principal at Gilead Connecticut, Inc. Education includes undergraduate studies at the University of California, Berkeley, a doctorate from The University of California, San Francisco, and an MBA from Harvard Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.06.2026 | 1’130 ( 0% ) | 5 130 $ | 31.08.2026 |
Aktive Positionen von Anupam Dalal
| Unternehmen | Position | Beginn |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 26.08.2021 |
Acuta Capital Partners LLC
 Acuta Capital Partners LLC Investment ManagersFinance Acuta invests in companies that seek to improve the health and well-being of individuals through research and innovation. The firm’s fundamental investment philosophy is summarized by a few tenets: bottom-up analysis, absolute-value oriented investing, and a willingness to take a long-term perspective in a very short-term oriented market. | Vorstandsvorsitzender | 01.12.2017 |
Aerpio Therapeutics LLC
 Aerpio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases | Direktor/Vorstandsmitglied | - |
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Anupam Dalal
| Unternehmen | Position | Ende |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 16.09.2016 |
Kearny Venture Partners
 Kearny Venture Partners Investment ManagersFinance Kearny Venture Partners invests in companies located in the United States. The firm focuses on healthcare and healthcare product sector. It participates in early stage transactions. | Private Equity Investor | 01.01.2016 |
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Private Equity Investor | 30.03.2006 |
Resolvyx Pharmaceuticals, Inc.
 Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for inflammatory diseases | Corporate Officer/Principal | - |
Pervasis Therapeutics, Inc.
 Pervasis Therapeutics, Inc. Medical SpecialtiesHealth Technology Produce biologically active vascular technologies | Corporate Officer/Principal | - |
Ausbildung von Anupam Dalal
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
54
Beziehungen ersten Grades
18
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 18 |
|---|---|
Pervasis Therapeutics, Inc.
Pervasis Therapeutics, Inc. Medical SpecialtiesHealth Technology Produce biologically active vascular technologies | Health Technology |
Resolvyx Pharmaceuticals, Inc.
Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for inflammatory diseases | Health Technology |
Aerpio Therapeutics LLC
Aerpio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases | Health Technology |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Neurotech Pharmaceuticals, Inc. (United States)
 Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Designs and develops therapeutic systems for retinal diseases | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gilead Connecticut, Inc.
 Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and biotechnology chemicals | Health Technology |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Kearny Venture Partners
Kearny Venture Partners Investment ManagersFinance Kearny Venture Partners invests in companies located in the United States. The firm focuses on healthcare and healthcare product sector. It participates in early stage transactions. | Finance |
NewBridge Pharmaceuticals FZ LLC
 NewBridge Pharmaceuticals FZ LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals, therapeutics, and medical devices | Health Technology |
Taiwan Liposome Co., Ltd.
 Taiwan Liposome Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Health Technology |
Acuta Capital Partners LLC
Acuta Capital Partners LLC Investment ManagersFinance Acuta invests in companies that seek to improve the health and well-being of individuals through research and innovation. The firm’s fundamental investment philosophy is summarized by a few tenets: bottom-up analysis, absolute-value oriented investing, and a willingness to take a long-term perspective in a very short-term oriented market. | Finance |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aerpio Pharmaceuticals, Inc.
 Aerpio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Aadi Subsidiary, Inc.
Aadi Subsidiary, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Kvp Capital Gp LLC |
